KORU Medical Systems (NASDAQ:KRMD - Free Report) had its target price upped by Canaccord Genuity Group from $3.00 to $4.00 in a research note released on Thursday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock.
Several other analysts have also issued reports on KRMD. B. Riley initiated coverage on KORU Medical Systems in a research note on Thursday, July 25th. They issued a "buy" rating and a $4.00 price objective on the stock. Piper Sandler increased their price target on KORU Medical Systems from $3.00 to $3.50 and gave the company an "overweight" rating in a research note on Thursday.
View Our Latest Stock Report on KRMD
KORU Medical Systems Stock Performance
Shares of KRMD traded down $0.12 during midday trading on Thursday, reaching $3.08. The stock had a trading volume of 98,985 shares, compared to its average volume of 114,756. The firm has a market cap of $141.23 million, a PE ratio of -12.32 and a beta of 0.41. The firm has a 50 day simple moving average of $2.64 and a 200-day simple moving average of $2.46. KORU Medical Systems has a one year low of $1.98 and a one year high of $3.40. The company has a current ratio of 3.77, a quick ratio of 3.27 and a debt-to-equity ratio of 0.01.
Hedge Funds Weigh In On KORU Medical Systems
A number of large investors have recently made changes to their positions in KRMD. Vanguard Group Inc. increased its holdings in shares of KORU Medical Systems by 2.7% during the first quarter. Vanguard Group Inc. now owns 1,961,764 shares of the company's stock worth $4,630,000 after purchasing an additional 51,890 shares during the period. Aaron Wealth Advisors LLC bought a new stake in shares of KORU Medical Systems during the 2nd quarter valued at $28,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of KORU Medical Systems during the 2nd quarter worth $107,000. Legato Capital Management LLC bought a new position in shares of KORU Medical Systems in the second quarter worth $35,000. Finally, Allspring Global Investments Holdings LLC acquired a new position in KORU Medical Systems in the second quarter valued at about $28,000. Institutional investors own 58.60% of the company's stock.
About KORU Medical Systems
(
Get Free Report)
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
Featured Articles
Before you consider KORU Medical Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KORU Medical Systems wasn't on the list.
While KORU Medical Systems currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
